Genetic targets for the prediction, diagnosis, and treatment of IgA nephropathy
- Summary
- This technology is a diagnostic tool to assess patients’ risk of IgA nephropathy based on the presence or absence of seven specific alleles.
- Technology Benefits
- Non-invasive assay doesn’t require a renal biopsyQuantitative risk assessmentIdentifies novel targets for future therapeuticsSimple to implement in a clinical setting
- Technology Application
- Non-invasive diagnostic assay for IgA nephropathyTherapeutic targets for IgA nephropathyResearch tool for studying the genetic mechanism of IgA nephropathy pathology
- Detailed Technology Description
- None
- *Abstract
-
None
- *Inquiry
- Jerry KokoshkaColumbia Technology VenturesTel: (212) 854-8444Email: TechTransfer@columbia.edu
- *IR
- 2798
- *Principal Investigator
-
- *Publications
- Gharavi AG, Kiryluk K, Choi M, Li Y, Hou P, Xie J, et al. “Genome-wide association study identifies susceptibility loci for IgA nephropathy.” Nature Genetics. 2011 Mar 13;43(4): 321-7.Tech Ventures Reference:IR 2798Licensing Contact: Jerry Kokoshka
- Country/Region
- USA
For more information, please click Here

